Expertise in
23
conditions

Dr. Nduka M. Amankulor

Neurosurgery
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
23
conditions
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 

Overview

Nduka Amankulor is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania.

Dr. Amankulor is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Dr. Amankulor is board certified in Neurological Surgery, 2017. He is actively involved in clinical research, co-authoring 86 peer reviewed articles and participating in 4 clinical trials. Dr. Amankulor is currently accepting new patients.

Specialties

Neurosurgery

Licenses

Neurological Surgery in PA

Board Certifications

Neurological Surgery, 2017

Hospital Affiliations

Hospital Of Univ Of Pennsylvania
Pennsylvania Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 9 Less Insurance Carriers -

Locations

Penn Neuroscience Center - Neurosurgery
3400 Civic Center Boulevard, South Pavilion, 2nd Floor, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Amankulor has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Ependymoma
Glioblastoma
Oligodendroglioma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Study Determining the Efficacy of Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases
Phase II Study Determining the Efficacy of Pre-operative Stereotactic Radiosurgery Followed by Resection for Brain Metastases
Enrollment Status: Completed
Publish Date: June 26, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined With Standard of Care for Newly Diagnosed High-Grade Gliomas
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Radiation, Biological, Other, Drug
Study Drugs: AdV-tk, Valacyclovir, Temozolomide, Nivolumab
Study Phase: Phase 1
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
View 3 Less Clinical Trials

85 Total Publications

Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.
Journal: Journal of neuro-oncology
Published: March 11, 2026
Similar Doctors
Expertise in
28
conditions
Expertise in
28
conditions
Referral may be required
Before you request

Penn Gamma Knife Center

801 Spruce Street, Spruce Building, 1st Floor, 
Philadelphia, PA 
 (2.0 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald O'rourke is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania. Dr. O'rourke is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy. Dr. O'rourke is board certified in Neurological Surgery, 1998. Dr. O'rourke is currently accepting new patients.

Expertise in
21
conditions
Dr. Steven Brem
Neurosurgery
Expertise in
21
conditions
Dr. Steven Brem
Neurosurgery
Referral may be required

Trustees Of The University Of Pennsylvania

3400 Spruce St, 
Philadelphia, PA 
 (0.2 miles away)
215-662-3487
Languages Spoken:
English
See accepted insurances

Steven Brem is a Neurosurgery provider practicing medicine in Philadelphia, Pennsylvania. Dr. Brem is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gastrostomy.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Vickie And Jack Farber Institute For Neuroscience At Jefferson

380 North Oxford Valley Road, 
Langhorne, PA 
 (23.6 miles away)
215-757-3980
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pascal Jabbour is a Neurosurgery provider practicing medicine in Langhorne, Pennsylvania. Dr. Jabbour is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Stroke, Subarachnoid Hemorrhage, Thrombectomy, and Stent Placement. Dr. Jabbour is board certified in American Board Of Neurological Surgery and Neurological Surgery. Dr. Jabbour is currently accepting new patients.

Frequently Asked Questions about Dr. Nduka M. Amankulor

How do I make an appointment with Dr. Nduka M. Amankulor?

You can book an appointment with Dr. Nduka M. Amankulor by calling their office at 215-662-3487. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nduka M. Amankulor a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nduka M. Amankulor is classified as an Elite expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nduka M. Amankulor specialize in?

While Dr. Nduka M. Amankulor is a Neurosurgery, they have specific expertise in Glioma, Astrocytoma, and Glioblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Nduka M. Amankulor participate in research or clinical trials?

Yes. Dr. Nduka M. Amankulor has published 85 articles and abstracts on conditions like Glioma. You can view a list of Dr. Nduka M. Amankulor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nduka M. Amankulor accept my insurance?

Dr. Nduka M. Amankulor accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 215-662-3487 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Amankulor's expertise for a condition
ConditionClose
View All 12 Distinguished Conditions
View All 7 Advanced Conditions
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile